Aimée R. Kreimer

Noninferiority of One HPV Vaccine Dose to Two Doses

Aimée R. Kreimer, Carolina Porras, Danping Liu, Allan Hildesheim et autres

BACKGROUND: Multidose human papillomavirus (HPV) vaccination is efficacious, yet the vaccine has been underused globally. Emerging data suggest that a single dose may provide protection. Whether a single dose of HPV vaccine would provide similar protection to two doses is uncertain. METHODS: …

us, cr, fr (code pays fourni par la source)

Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica

Cameron B. Haas, Rebeca Ocampo, Danping Liu, Michael Zúñiga et autres

Anal cancer is caused by HPV, and its incidence has increased globally over the last five decades. We conducted an anal HPV natural history study nested in the Costa Rica HPV Vaccine Trial (CVT) to quantitatively describe the natural history and clinical …

us, cr (code pays fourni par la source)

Validation of TypeSeq2, a Next-Generation–Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories

Mónica S. Sierra, Carolina Porras, Rolando Herrero, Daniela Ugalde et autres

BACKGROUND: Cervical cancer is caused by persistent infection with carcinogenic human papillomavirus (HPV) genotypes. Prophylactic HPV vaccines are highly efficacious in preventing the acquisition of HPV infection. HPV vaccine trials and epidemiologic studies based on virologic endpoints rely on valid and reproducible …

us, cr (code pays fourni par la source)

Supplementary Table 2 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Associations between sexual behaviours and HPV groupings in Natsal-2 and Natsal-3. Sensitivity analysis showing age- and survey-adjusted odds ratios (aOR) between sexual behaviours and different non-vaccine HPV infection groupings among women aged 18 to 44 in Natsal-2 and Natsal-3 (n = 4256)

Supplementary Figure 1 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Prevalence of NVP-HPV (26/53/66/70/73) and HPV 16/18 by age group, 2008 to 2020. Graph demonstrates prevalence of NVP-HPV and HPV 16/18 between 2008 and 2020 by age grouping among 24,707 16 to 24 year old women included in UKHSA HPV surveillance.

Supplementary Figure 2 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Prevalence of NVP-HPV (26/53/66/70/73) and HPV 16/18 by birth cohort, 2008 to 2020. Graph demonstrates prevalence of NVP-HPV and HPV 16/18 by birth cohort among 24,707 16 to 24 year old women included in UKHSA HPV surveillance.

Supplementary Table 3 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Characteristics associated with non-vaccine HPV infection among women in Natsal-2 and Natsal-3. Associations analysis showing age-adjusted odds ratios (aOR) between characteristics and non-vaccine-preventable HPV infection separately for Natsal-2 (n = 1849) and Natsal-3 (n = 2407), and differences in trends between the …

Supplementary Table 5 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Characteristics of women in Natsal-2 and Natsal-3. Descriptive table including sociodemographic and behavioural characteristics of women aged 18 to 44 years in Natsal-2 (n = 1849) and Natsal-3 (n = 2407) surveys.

Supplementary Table 1 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

HPV groupings. HPV genotypes used in different analysis groups and assay characteristics.

Supplementary Table 4 from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

Characteristics associated with NVP-HPV in Natsal-2 and Natsal-3. Analysis showing age- and survey-adjusted odds ratios (aOR) between sexual behaviours and non-vaccine HPV infection (NVP-HPV) among women aged 18 to 44 in Natsal-2 and Natsal-3 (n = 4256)

Data from Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination

Emily Dema, Jaimie Z. Shing, Marta Checchi, Simon Beddows et autres

AbstractBackground: Evaluating the impact/effectiveness of human papillomavirus (HPV) vaccination generally assumes stability in factors driving transmission, which might not be valid. We aimed to develop, validate, and test a grouping of non-vaccine–preventable HPV (NVP-HPV) types as a molecular indicator associated with sexual …

Suboptimal Quality of Health Care and Associated Socioeconomic Factors Among Cancer Survivors During the COVID-19 Pandemic: A Cross-Sectional Study

Erica S Stephens, Jun Tao, Jereme Corbin, Aimée R. Kreimer et autres

We described disruptions in cancer-related healthcare appointments and perceived quality of healthcare during the COVID-19 pandemic and identified predictors, including socioeconomic factors, of perceived quality of healthcare among cancer survivors. In this cross-sectional study, we used 2021 Health Information National Trends Survey-Surveillance, …

us (code pays fourni par la source)